Year: 2023
Type: dissertation
Abstract: Current treatment options against chronic hepatitis B virus (HBV) infection are rarely curative and represent a significant global health burden. Novel therapeutic approaches directly target the immune system or indirectly enhance antiviral immunity through impeding with viral antigen production or viral lifecycle, yet immunological biomarkers are highly lacking beyond clinical assays for antibodies to HBsAg and HBeAg. In order to characterize immunological mechanisms of action and guide clinical decisions for the use of immunotherapeutic agents, immune assays that can measure T cell functionality or predict liver inflammation are highly sought after. Overall, our work builds upon the current understanding of host immunology during CHB infection and aims to establish immunological biomarkers in pursuit of defining curative strategies against HBV infection.
Source: TSpace (University of Toronto)
Author: Chua, Conan
Institution: University of Toronto
Language: English
Topic: Hepatitis B Virus Studies
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7132922897
